Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial.
Mulvagh SL, Inzucchi SE, Marx N, Poulter NR, Deanfield JE 等23人
📖 JAMA Cardiol
📅 2026 Mar 25
📄 查看详情
Incidence, Predictors, Management, and Clinical Impact of Major Bleeding Following Left Atrial Appendage Occlusion: The Amulet IDE Randomized Clinical Trial.
Schmidt B, Windecker S, Thaler D, Ellis CR, Nielsen-Kudsk JE 等11人
📖 JAMA Cardiol
📅 2026 Mar 25
📄 查看详情
Hypertension-Associated Acetate Deficiency Enhances Platelet Activation and Thrombosis Via Olfr78.
Chen Y, Li B, Lin Y, Sha W, Shi C 等17人
📖 Circ Res
📅 2026 Mar 25
📄 查看详情
SARM1 Regulates BNIP3-Mediated Mitochondrial Quality Control in Diabetic Hearts.
Nizami HL, Minor KE, Szybowska PE, Gorecki I, Best L 等10人
📖 Circ Res
📅 2026 Mar 13
📄 查看详情
Angiography-derived fractional flow reserve versus coronary angiography to guide coronary artery bypass grafting in patients undergoing surgical valve procedures with concomitant coronary artery disease in China (FAVOR IV-QVAS): a multicentre, triple-blind, randomised trial.
Yunpeng Zhu (Department of Cardiovascular Surgery/China), Zhaoyun Cheng (Department of Cardiac Surgery/China), Yuan Zhao (Department of Cardiovascular Surgery/China), Lin Han (Department of Cardiovascular Surgery/China), Wei Zhang (Department of Biostatistics/China) 等29人
📖 Lancet
📅 2026-03-21
📄 查看详情
Suppressor of variegation 3-9 homolog 1 deficiency attenuates cardiac fibrosis and rescues heart failure through TACC2.
Chenghao Zhu (State Key Laboratory of Natural Medicines/China), Yujia Xue (State Key Laboratory of Natural Medicines/China), Wenxuan Hong (Department of Cardiology/China), Yuwen Zhu (Department of Laboratory Medicine/China), Xiulian Miao (Institute of Biomedical Research/China) 等9人
📖 Cardiovasc Res
📅 2026-03-20
cardiac fibroblast
cardiac fibrosis
epigenetics
myofibroblast
transcriptional regulation
📄 查看详情
海洋之心